Precision Wealth Strategies, LLC Moderna, Inc. Transaction History

Precision Wealth Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $28,795 - $39,008	-243 Reduced 8.0%	2,796 $339,000
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $48,973 - $71,124	-361 Reduced 10.62%	3,039 $466,000
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $228,473 - $405,377	-1,930 Reduced 36.21%	3,400 $610,000
Q3 2022 Oct 25, 2022	SELL	$118.07 - $194.18 $436,386 - $717,689	-3,696 Reduced 40.95%	5,330 $709,000
Q2 2022 Jul 14, 2022	SELL	$117.13 - $176.59 $585 - $882	-5 Reduced 0.06%	9,026 $1.55 Million
Q1 2022 May 04, 2022	BUY	$126.46 - $235.05 $519,750 - $966,055	4,110 Added 83.52%	9,031 $1.56 Million
Q4 2021 Jan 19, 2022	BUY	$225.82 - $368.51 $4,516 - $7,370	20 Added 0.41%	4,921 $1.25 Million
Q3 2021 Nov 02, 2021	SELL	$221.9 - $484.47 $44,380 - $96,894	-200 Reduced 3.92%	4,901 $1.89 Million
Q2 2021 Jul 22, 2021	SELL	$129.91 - $234.98 $145,369 - $262,942	-1,119 Reduced 17.99%	5,101 $1.2 Million
Q1 2021 Apr 26, 2021	SELL	$109.18 - $185.98 $25,220 - $42,961	-231 Reduced 3.58%	6,220 $815,000
Q4 2020 Apr 26, 2021	BUY	$65.74 - $169.86 $424,088 - $1.1 Million	6,451 New	6,451 $674,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Precision Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Precision Wealth Strategies, LLC with notifications on news.